Dr. Anne Rositch is the Senior Director of Health Outcomes and Real World Evidence in the Diagnostics Division at Hologic and an Adjunct Associate Professor at Johns Hopkins University. She is a global women’s health researcher, concentrating on cancer prevention and control in women and global cancer disparities, with a background in basic science and experience leading international field-based research. Dr. Rositch received her PhD in Epidemiology (Infectious Diseases) from the University of North Carolina at Chapel Hill, and completed a post-doctoral fellowship in Cancer Epidemiology at Johns Hopkins. For over 15 years, her research has focused on HPV and cervical cancer in people living with HIV, aging women, and in low-resource settings. It has spanned the translational spectrum from epidemiological studies to re-define the natural history of the disease, to studying the effectiveness and implementation of cervical cancer prevention in low-resource settings. Her most recent work is focused on leveraging her training in Implementation Science to identify novel multidisciplinary and multilevel approaches for cancer control in low- and middle-income countries.
Prior to joining Hologic, Dr. Rositch was an Associate Professor in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health, with a joint appointment in the Program in Oncology at the Johns Hopkins School of Medicine and a member of the Sidney Kimmel Comprehensive Cancer Center. At Johns Hopkins, Dr. Rositch directed the Doctoral Program in Epidemiology, served as a faculty mentor on two NIH T32 training grants focused on HIV and cancer, and mentored over 50 graduate, medical, and post-graduate trainees in her global cancer research program. She has published over 120 scientific publications and been awarded independent research grants from the NIH National Cancer Institute, American Cancer Society, Susan G. Komen and more for her work in the United States, Peru, and across sub-Saharan Africa, including Tanzania, Nigeria, and South Africa. Through her multidisciplinary research programs, engagement with a global network of stakeholders, and leadership activities, she is committed to finding practical ways to translate existing and new interventions for cancer prevention and control to populations with the highest burden of disease, globally and locally.